Dianthus Therapeutics, Inc. (DNTH)
50.75
+4.17
(+8.95%)
USD |
NASDAQ |
Feb 06, 16:00
50.71
-0.04
(-0.08%)
After-Hours: 20:00
Dianthus Therapeutics Total Liabilities (Quarterly) : 30.99M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cartesian Therapeutics, Inc. | 408.52M |
| Royalty Pharma Plc | 9.726B |
| ACADIA Pharmaceuticals, Inc. | 413.50M |
| Agenus, Inc. | 514.76M |
| Alnylam Pharmaceuticals, Inc. | 4.618B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 577.44M |
| Shareholders Equity (Quarterly) | 546.45M |
| Debt to Equity Ratio | 0.0024 |
| Current Ratio | 17.35 |
| Net Debt Paydown Yield | -0.01% |